Details
Title
Impact of the kinetics of circulating anti-CD19 CAR-T cells and their populations on the outcome of DLBCL patients
Author
Martín-Martín, Lourdes 1
; Gutiérrez-Herrero, Sara 2
; Herrero-García, María 2
; Martín García-Sancho, Alejandro 3
; Yeguas, Ana 4 ; Martín-López, Ana-África 3 ; López-Corral, Lucía 3
; Pérez-López, Estefanía 3 ; García-Blázquez, Marta 5 ; Sánchez-Guijo, Fermín 3
; Vidriales, María Belén 3
; Gaipa, Giuseppe 6 ; Orfao, Alberto 1
1 and University of Salamanca, Translational and Clinical Research Program, Centro de Investigación del Cáncer and Instituto de Biología Molecular y Celular del Cáncer (IBMCC), Consejo Superior de Investigaciones Científicas (CSIC), Salamanca, Spain (GRID:grid.11762.33) (ISNI:0000 0001 2180 1817); University of Salamanca, Flow Cytometry Service (NUCLEUS), Salamanca, Spain (GRID:grid.11762.33) (ISNI:0000 0001 2180 1817); Institute of Biomedical Research of Salamanca (IBSAL), Salamanca, Spain (GRID:grid.452531.4); University of Salamanca (Universidad de Salamanca), Department of Medicine, Salamanca, Spain (GRID:grid.11762.33) (ISNI:0000 0001 2180 1817); Carlos III Health Institute, Biomedical Research Networking Centre Consortium of Oncology (CIBERONC), Madrid, Spain (GRID:grid.413448.e) (ISNI:0000 0000 9314 1427)
2 and University of Salamanca, Translational and Clinical Research Program, Centro de Investigación del Cáncer and Instituto de Biología Molecular y Celular del Cáncer (IBMCC), Consejo Superior de Investigaciones Científicas (CSIC), Salamanca, Spain (GRID:grid.11762.33) (ISNI:0000 0001 2180 1817); University of Salamanca, Flow Cytometry Service (NUCLEUS), Salamanca, Spain (GRID:grid.11762.33) (ISNI:0000 0001 2180 1817); Institute of Biomedical Research of Salamanca (IBSAL), Salamanca, Spain (GRID:grid.452531.4); University of Salamanca (Universidad de Salamanca), Department of Medicine, Salamanca, Spain (GRID:grid.11762.33) (ISNI:0000 0001 2180 1817)
3 Institute of Biomedical Research of Salamanca (IBSAL), Salamanca, Spain (GRID:grid.452531.4); University of Salamanca (Universidad de Salamanca), Department of Medicine, Salamanca, Spain (GRID:grid.11762.33) (ISNI:0000 0001 2180 1817); Carlos III Health Institute, Biomedical Research Networking Centre Consortium of Oncology (CIBERONC), Madrid, Spain (GRID:grid.413448.e) (ISNI:0000 0000 9314 1427); University Hospital of Salamanca, Department of Hematology, Salamanca, Spain (GRID:grid.425910.b) (ISNI:0000 0004 1789 862X)
4 Institute of Biomedical Research of Salamanca (IBSAL), Salamanca, Spain (GRID:grid.452531.4); University of Salamanca (Universidad de Salamanca), Department of Medicine, Salamanca, Spain (GRID:grid.11762.33) (ISNI:0000 0001 2180 1817); University Hospital of Salamanca, Department of Hematology, Salamanca, Spain (GRID:grid.425910.b) (ISNI:0000 0004 1789 862X)
5 University Hospital of Salamanca, Department of Hematology, Salamanca, Spain (GRID:grid.425910.b) (ISNI:0000 0004 1789 862X)
6 Fondazione IRCCS San Gerardo dei Tintori, Tettamanti Center and Pediatrics, Monza, Italy (GRID:grid.415025.7) (ISNI:0000 0004 1756 8604)
; Gutiérrez-Herrero, Sara 2
; Herrero-García, María 2
; Martín García-Sancho, Alejandro 3
; Yeguas, Ana 4 ; Martín-López, Ana-África 3 ; López-Corral, Lucía 3
; Pérez-López, Estefanía 3 ; García-Blázquez, Marta 5 ; Sánchez-Guijo, Fermín 3
; Vidriales, María Belén 3
; Gaipa, Giuseppe 6 ; Orfao, Alberto 1 1 and University of Salamanca, Translational and Clinical Research Program, Centro de Investigación del Cáncer and Instituto de Biología Molecular y Celular del Cáncer (IBMCC), Consejo Superior de Investigaciones Científicas (CSIC), Salamanca, Spain (GRID:grid.11762.33) (ISNI:0000 0001 2180 1817); University of Salamanca, Flow Cytometry Service (NUCLEUS), Salamanca, Spain (GRID:grid.11762.33) (ISNI:0000 0001 2180 1817); Institute of Biomedical Research of Salamanca (IBSAL), Salamanca, Spain (GRID:grid.452531.4); University of Salamanca (Universidad de Salamanca), Department of Medicine, Salamanca, Spain (GRID:grid.11762.33) (ISNI:0000 0001 2180 1817); Carlos III Health Institute, Biomedical Research Networking Centre Consortium of Oncology (CIBERONC), Madrid, Spain (GRID:grid.413448.e) (ISNI:0000 0000 9314 1427)
2 and University of Salamanca, Translational and Clinical Research Program, Centro de Investigación del Cáncer and Instituto de Biología Molecular y Celular del Cáncer (IBMCC), Consejo Superior de Investigaciones Científicas (CSIC), Salamanca, Spain (GRID:grid.11762.33) (ISNI:0000 0001 2180 1817); University of Salamanca, Flow Cytometry Service (NUCLEUS), Salamanca, Spain (GRID:grid.11762.33) (ISNI:0000 0001 2180 1817); Institute of Biomedical Research of Salamanca (IBSAL), Salamanca, Spain (GRID:grid.452531.4); University of Salamanca (Universidad de Salamanca), Department of Medicine, Salamanca, Spain (GRID:grid.11762.33) (ISNI:0000 0001 2180 1817)
3 Institute of Biomedical Research of Salamanca (IBSAL), Salamanca, Spain (GRID:grid.452531.4); University of Salamanca (Universidad de Salamanca), Department of Medicine, Salamanca, Spain (GRID:grid.11762.33) (ISNI:0000 0001 2180 1817); Carlos III Health Institute, Biomedical Research Networking Centre Consortium of Oncology (CIBERONC), Madrid, Spain (GRID:grid.413448.e) (ISNI:0000 0000 9314 1427); University Hospital of Salamanca, Department of Hematology, Salamanca, Spain (GRID:grid.425910.b) (ISNI:0000 0004 1789 862X)
4 Institute of Biomedical Research of Salamanca (IBSAL), Salamanca, Spain (GRID:grid.452531.4); University of Salamanca (Universidad de Salamanca), Department of Medicine, Salamanca, Spain (GRID:grid.11762.33) (ISNI:0000 0001 2180 1817); University Hospital of Salamanca, Department of Hematology, Salamanca, Spain (GRID:grid.425910.b) (ISNI:0000 0004 1789 862X)
5 University Hospital of Salamanca, Department of Hematology, Salamanca, Spain (GRID:grid.425910.b) (ISNI:0000 0004 1789 862X)
6 Fondazione IRCCS San Gerardo dei Tintori, Tettamanti Center and Pediatrics, Monza, Italy (GRID:grid.415025.7) (ISNI:0000 0004 1756 8604)
Pages
83
Publication year
2024
Publication date
Dec 2024
e-ISSN
20445385
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
3056070167
Copyright
© The Author(s) 2024. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.